Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Pharmalittle: We’re reading about Trump and drug prices, an FDA plan for U.S. manufacturing, and more

0 Mins
The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to cut drug costs in the U.S.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago